Home > Healthcare > Medical Devices > Therapeutic Devices > Cardiac Ablation Market
Cardiac Ablation Market size was valued at over USD 3.5 billion in 2022 and is projected to observe over 13.5% CAGR between 2023 to 2032.
High caffeine intake, adoption of a sedentary lifestyle, overconsumption of alcohol and tobacco, substance abuse, and smoking habits are factors that are likely to contribute to increasing occurrences of cardiac ailments. As per WHO, over 1.9 million people across the world die due to tobacco-related cardiac disorders each year. Other estimates from the American Heart Association (AHA) suggest that cardiovascular ailments account for nearly 800,000 U.S. deaths annually, of which 20% of cases are due to cigarette smoking.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Cardiac Ablation Market Size in 2022: | 3.5 Billion (USD) |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 13.5% |
2032 Value Projection: | 14.5 Billion (USD) |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 175 |
Tables, Charts & Figures: | 262 |
Segments covered: | Product, Approach, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
In the short run, the risks related to cardiac ablation procedures may hinder cardiac ablation market progress. Some of the cardiac ablation surgery-related risks include infections, damage to blood vessels, and pulmonary stenosis. Moreover, a rare complication associated with catheter-based ablation is the development of an atrial-esophageal fistula and esophageal injury is likely to affect patient preference for the procedure. As per the Journal of AHA, 1 in 18 patients undergoing atrial fibrillation ablation encountered a procedural complication within 30 days of hospital discharge with bleeding and pericardial effusion.